LTFS
HQL

Ladenburg Thalmann Financial Services’s abrdn Life Sciences Investors HQL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$862K Sell
49,430
-12,445
-20% -$204K 0.01% 1388
2019
Q3 		$934K Buy
61,875
+13,400
+28% +$215K 0.01% 1294
2019
Q2 		$818K Sell
48,475
-12,882
-21% -$212K 0.01% 1364
2019
Q1 		$1.05M Buy
61,357
+5,446
+10% +$94K 0.01% 1158
2018
Q4 		$845K Buy
55,911
+1,001
+2% +$17.6K 0.01% 1156
2018
Q3 		$1.12M Sell
54,910
-1,924
-3% -$38.3K 0.01% 1053
2018
Q2 		$1.09M Hold
56,834
– – 0.01% 1019
2018
Q1 		$1.09M Sell
56,834
-1,331
-2% -$26.7K 0.01% 1019
2017
Q4 		$1.14M Buy
58,165
+2,448
+4% +$49K 0.01% 990
2017
Q3 		$1.2M Buy
55,717
+2,531
+5% +$53.8K 0.01% 882
2017
Q2 		$1.11M Buy
53,186
+2,230
+4% +$45.1K 0.01% 884
2017
Q1 		$988K Buy
50,956
+619
+1% +$11.5K 0.01% 905
2016
Q4 		$855K Buy
50,337
+1,931
+4% +$33.9K 0.01% 923
2016
Q3 		$907K Buy
48,406
+2,215
+5% +$41.8K 0.01% 850
2016
Q2 		$794K Sell
46,191
-2,933
-6% -$54.1K 0.01% 868
2016
Q1 		$881K Sell
49,124
-589
-1% -$10.7K 0.02% 762
2015
Q4 		$1.18M Buy
49,713
+1,005
+2% +$24.9K 0.02% 613
2015
Q3 		$1.1M Buy
48,708
+32,174
+195% +$901K 0.02% 593
2015
Q2 		$466K Buy
16,534
+6,082
+58% +$169K 0.01% 1084
2015
Q1 		$288K Buy
10,452
+932
+10% +$25.4K 0.01% 1339
2014
Q4 		$237K Buy
9,520
+2,162
+29% +$51.9K 0.01% 1310
2014
Q3 		$163K Buy
7,358
+27
+0.4% +$586 ﹤0.01% 1324
2014
Q2 		$152K Buy
7,331
+27
+0.4% +$567 ﹤0.01% 1349
2014
Q1 		$159K Buy
7,304
+387
+6% +$8.61K ﹤0.01% 1254
2013
Q4 		$141K Buy
6,917
+108
+2% +$2.1K ﹤0.01% 1253
2013
Q3 		$131K Buy
6,809
+94
+1% +$1.8K ﹤0.01% 1231
2013
Q2 		$120K Buy
+6,715
New +$121K ﹤0.01% 1225

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Ladenburg Thalmann Financial Services's HQL Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its abrdn Life Sciences Investors (HQL) stake by 20% in Q4 2019, selling an estimated $204K and leaving 49,430 shares worth $862K. The position accounts for 0.01% of the portfolio, ranked #1388.

Ladenburg Thalmann Financial Services first reported a position in HQL in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.2M in Q3 2017. 69 funds tracked by Wall St. Rank hold HQL as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 49,430 shares of abrdn Life Sciences Investors worth $862K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 12,445 abrdn Life Sciences Investors shares in Q4 2019, an estimated $204K.
  • abrdn Life Sciences Investors made up 0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1388 holding.
  • Ladenburg Thalmann Financial Services first reported a position in abrdn Life Sciences Investors in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's abrdn Life Sciences Investors position peaked at $1.2M in Q3 2017.
  • 69 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.